耐受性-话题@MedSci

#耐受性#

144篇内容 | 4040人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1417677, encodeId=ac0f141e677e6, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Lancet oncol：Larotrectinib用于携带TRK融合基因的肿瘤患儿，疗效明显且耐受性好, objectType=article, longId=133863, objectId=6f041338630c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f041338630c, replyNumber=0, likeNumber=62, createdTime=2018-04-01, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f041338630c, moduleTitle=Lancet oncol：Larotrectinib用于携带TRK融合基因的肿瘤患儿，疗效明显且耐受性好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f041338630c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417676, encodeId=8b0a141e67665, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Blood：CLL患者长期应用依鲁替尼耐受性良好，且可获得持久的病程控制, objectType=article, longId=130928, objectId=73ee130928ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73ee130928ad, replyNumber=0, likeNumber=71, createdTime=2018-03-02, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73ee130928ad, moduleTitle=Blood：CLL患者长期应用依鲁替尼耐受性良好，且可获得持久的病程控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73ee130928ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417675, encodeId=c041141e675f3, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Lancet：21种抗抑郁药对成人重度抑郁疗效及耐受性比较研究, objectType=article, longId=130289, objectId=8f66130289ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f66130289ac, replyNumber=0, likeNumber=65, createdTime=2018-02-24, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f66130289ac, moduleTitle=Lancet：21种抗抑郁药对成人重度抑郁疗效及耐受性比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f66130289ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417674, encodeId=8b26141e67431, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Blood：阿伐他丁可增强糖皮质激素耐受性的免疫性血小板减少性紫癜患者的骨髓内皮细胞的功能。, objectType=article, longId=125208, objectId=c66f1252082a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c66f1252082a, replyNumber=0, likeNumber=55, createdTime=2018-01-02, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c66f1252082a, moduleTitle=Blood：阿伐他丁可增强糖皮质激素耐受性的免疫性血小板减少性紫癜患者的骨髓内皮细胞的功能。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c66f1252082a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417673, encodeId=9cc6141e673cb, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Liver Int：原位肝移植后，DAA药物联合治疗丙型肝炎复发患者，展示出良好的疗效且耐受性良好, objectType=article, longId=123103, objectId=43c5123103be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43c5123103be, replyNumber=0, likeNumber=93, createdTime=2017-12-13, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43c5123103be, moduleTitle=Liver Int：原位肝移植后，DAA药物联合治疗丙型肝炎复发患者，展示出良好的疗效且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43c5123103be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417672, encodeId=60a9141e672aa, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Ann Rheum Dis：糖皮质激素在早期类风湿关节炎患者中的耐受性如何？, objectType=article, longId=121684, objectId=d94e121684a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d94e121684a4, replyNumber=0, likeNumber=50, createdTime=2017-11-30, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d94e121684a4, moduleTitle=Ann Rheum Dis：糖皮质激素在早期类风湿关节炎患者中的耐受性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d94e121684a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417671, encodeId=8d31141e6717f, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=JCEM：降低胆固醇和脂肪摄入量通过增强非糖尿病患者的β细胞功能改善葡萄糖耐受性！, objectType=article, longId=118449, objectId=fed011844964, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fed011844964, replyNumber=0, likeNumber=75, createdTime=2017-11-03, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fed011844964, moduleTitle=JCEM：降低胆固醇和脂肪摄入量通过增强非糖尿病患者的β细胞功能改善葡萄糖耐受性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fed011844964)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417670, encodeId=f7d2141e670a0, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Eur Urol：之前接受雄激素剥夺疗法（加或不加用多西紫杉醇）的转移未去势前列腺癌患者，进展后再治疗的抗癌活性和耐受性研究。, objectType=article, longId=118241, objectId=3b72118241ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b72118241ce, replyNumber=0, likeNumber=67, createdTime=2017-11-02, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b72118241ce, moduleTitle=Eur Urol：之前接受雄激素剥夺疗法（加或不加用多西紫杉醇）的转移未去势前列腺癌患者，进展后再治疗的抗癌活性和耐受性研究。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b72118241ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417669, encodeId=91ec141e6696e, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=J SEX MED：功能性磁共振成像扫描揭示了女性性高潮期间疼痛耐受性增加的原因，并表明大脑不会关闭, objectType=article, longId=116253, objectId=2401116253db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2401116253db, replyNumber=0, likeNumber=62, createdTime=2017-10-17, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2401116253db, moduleTitle=J SEX MED：功能性磁共振成像扫描揭示了女性性高潮期间疼痛耐受性增加的原因，并表明大脑不会关闭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2401116253db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417668, encodeId=65b0141e668cc, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Eur Respir J：FK506治疗肺动脉高压耐受性如何？, objectType=article, longId=115834, objectId=0bee11583438, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bee11583438, replyNumber=0, likeNumber=63, createdTime=2017-10-13, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bee11583438, moduleTitle=Eur Respir J：FK506治疗肺动脉高压耐受性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bee11583438)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417667, encodeId=de0a141e667ad, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Br J Dermatol：PF-04965842治疗中度至重度银屑病有效且耐受性良好, objectType=article, longId=114911, objectId=d41c1149111a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d41c1149111a, replyNumber=0, likeNumber=49, createdTime=2017-10-01, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d41c1149111a, moduleTitle=Br J Dermatol：PF-04965842治疗中度至重度银屑病有效且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d41c1149111a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417666, encodeId=86cb141e66648, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Respirology：吡非尼酮和尼达尼布治疗肺纤维化：耐受性和不良药物反应, objectType=article, longId=113201, objectId=c5d91132012a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5d91132012a, replyNumber=0, likeNumber=77, createdTime=2017-09-20, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5d91132012a, moduleTitle=Respirology：吡非尼酮和尼达尼布治疗肺纤维化：耐受性和不良药物反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5d91132012a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417665, encodeId=ad45141e665c4, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=J Sleep Res：父母对婴儿哭闹的低耐受性是婴儿睡眠问题的潜在因素吗？, objectType=article, longId=112450, objectId=773e112450ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=773e112450ac, replyNumber=0, likeNumber=64, createdTime=2017-09-11, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=773e112450ac, moduleTitle=J Sleep Res：父母对婴儿哭闹的低耐受性是婴儿睡眠问题的潜在因素吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=773e112450ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417664, encodeId=7e91141e66490, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=全球！测定HIV药物耐受性突变的NGS技术获批CE-IVD, objectType=article, longId=110850, objectId=b38f11085084, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b38f11085084, replyNumber=0, likeNumber=72, createdTime=2017-08-27, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b38f11085084, moduleTitle=全球！测定HIV药物耐受性突变的NGS技术获批CE-IVD, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b38f11085084)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417663, encodeId=bf76141e663c7, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=ANN RHEUM DIS：随机I期研究中重复注射dapirolizumab pegol耐受性良好，并伴随系统性红斑狼疮疾病活动改善和全血转录组学特征改变, objectType=article, longId=108003, objectId=15611080035b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15611080035b, replyNumber=0, likeNumber=29, createdTime=2017-08-09, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15611080035b, moduleTitle=ANN RHEUM DIS：随机I期研究中重复注射dapirolizumab pegol耐受性良好，并伴随系统性红斑狼疮疾病活动改善和全血转录组学特征改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15611080035b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417662, encodeId=85ed141e6620c, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Haematologica：Vosaroxin联合地西他滨治疗老年急性白血病或骨髓增生异常综合征，有效且耐受性良好, objectType=article, longId=106541, objectId=fee61065410a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fee61065410a, replyNumber=0, likeNumber=53, createdTime=2017-07-26, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fee61065410a, moduleTitle=Haematologica：Vosaroxin联合地西他滨治疗老年急性白血病或骨髓增生异常综合征，有效且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fee61065410a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417661, encodeId=04cf141e66109, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Blood : pembrolizumab治疗B细胞淋巴瘤的安全性和耐受性, objectType=article, longId=106516, objectId=1980106516d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1980106516d2, replyNumber=0, likeNumber=49, createdTime=2017-07-26, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1980106516d2, moduleTitle=Blood : pembrolizumab治疗B细胞淋巴瘤的安全性和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1980106516d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417660, encodeId=ccd5141e66033, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Diabetic Med：肾移植对葡萄糖耐受性受损的日本人的影响, objectType=article, longId=104779, objectId=733a104e79a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=733a104e79a2, replyNumber=0, likeNumber=78, createdTime=2017-07-08, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=733a104e79a2, moduleTitle=Diabetic Med：肾移植对葡萄糖耐受性受损的日本人的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=733a104e79a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417659, encodeId=d03b141e65976, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Diabetes：骨髓去乙酰化酶6缺乏会导致高脂喂养的小鼠诱发巨噬细胞极化的M1表型产生胰岛素耐受性, objectType=article, longId=102797, objectId=e2af102e9786, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2af102e9786, replyNumber=0, likeNumber=72, createdTime=2017-06-23, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2af102e9786, moduleTitle=Diabetes：骨髓去乙酰化酶6缺乏会导致高脂喂养的小鼠诱发巨噬细胞极化的M1表型产生胰岛素耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2af102e9786)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417658, encodeId=2a73141e65845, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Blood：CD38单克隆抗体——Daratumumab治疗免疫球蛋白轻链型淀粉样变耐受性和安全性良好, objectType=article, longId=102741, objectId=d3cb102e41ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3cb102e41ed, replyNumber=0, likeNumber=49, createdTime=2017-06-22, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3cb102e41ed, moduleTitle=Blood：CD38单克隆抗体——Daratumumab治疗免疫球蛋白轻链型淀粉样变耐受性和安全性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3cb102e41ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

耐受性

2020-05-29

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Lancet oncol：Larotrectinib用于携带TRK融合基因的肿瘤患儿，疗效明显且耐受性好

2018-04-01

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Blood：CLL患者长期应用依鲁替尼耐受性良好，且可获得持久的病程控制

2018-03-02

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Lancet：21种抗抑郁药对成人重度抑郁疗效及耐受性比较研究

2018-02-24

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Blood：阿伐他丁可增强糖皮质激素耐受性的免疫性血小板减少性紫癜患者的骨髓内皮细胞的功能。

2018-01-02

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Liver Int：原位肝移植后，DAA药物联合治疗丙型肝炎复发患者，展示出良好的疗效且耐受性良好

2017-12-13

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Ann Rheum Dis：糖皮质激素在早期类风湿关节炎患者中的耐受性如何？

2017-11-30

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

JCEM：降低胆固醇和脂肪摄入量通过增强非糖尿病患者的β细胞功能改善葡萄糖耐受性！

2017-11-03

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Eur Urol：之前接受雄激素剥夺疗法（加或不加用多西紫杉醇）的转移未去势前列腺癌患者，进展后再治疗的抗癌活性和耐受性研究。

2017-11-02

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

J SEX MED：功能性磁共振成像扫描揭示了女性性高潮期间疼痛耐受性增加的原因，并表明大脑不会关闭

2017-10-17

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Eur Respir J：FK506治疗肺动脉高压耐受性如何？

2017-10-13

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Br J Dermatol：PF-04965842治疗中度至重度银屑病有效且耐受性良好

2017-10-01

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Respirology：吡非尼酮和尼达尼布治疗肺纤维化：耐受性和不良药物反应

2017-09-20

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

J Sleep Res：父母对婴儿哭闹的低耐受性是婴儿睡眠问题的潜在因素吗？

2017-09-11

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

全球！测定HIV药物耐受性突变的NGS技术获批CE-IVD

2017-08-27

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

ANN RHEUM DIS：随机I期研究中重复注射dapirolizumab pegol耐受性良好，并伴随系统性红斑狼疮疾病活动改善和全血转录组学特征改变

2017-08-09

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Haematologica：Vosaroxin联合地西他滨治疗老年急性白血病或骨髓增生异常综合征，有效且耐受性良好

2017-07-26

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Blood : pembrolizumab治疗B细胞淋巴瘤的安全性和耐受性

2017-07-26

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Diabetic Med：肾移植对葡萄糖耐受性受损的日本人的影响

2017-07-08

柳叶一刀 (审核中...)

前往app查看评论内容

#耐受性#

Diabetes：骨髓去乙酰化酶6缺乏会导致高脂喂养的小鼠诱发巨噬细胞极化的M1表型产生胰岛素耐受性

2017-06-23

柳叶一刀 (审核中...)

前往app查看评论内容

#耐受性#

Blood：CD38单克隆抗体——Daratumumab治疗免疫球蛋白轻链型淀粉样变耐受性和安全性良好

2017-06-22

科室
- - 订阅+
  - 更多科室
工具
服务